{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:33:16Z","timestamp":1787236396058,"version":"build-2736575974"},"reference-count":19,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T00:00:00Z","timestamp":1092960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Artificial Organs"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:\u2002<\/jats:bold>\n                    The oxygen carried inside plasma performs differently than the oxygen carried inside red cells. Only 0.13\u20130.3\u2003mL of oxygen in 100\u2003mL of blood is available inside plasma while 14\u201319\u2003mL of oxygen is carried inside red cells. Thus, less than 5\u20138\u2003mL of oxygen is available in the plasma of the entire body. When a patient develops hypovolemic shock, red cells are bypassed and are not perfused directly inside the tissues. However, plasma should reach such hypoxic tissues. Thus, an infusion of oxygen\u2010carrying macromolecules in plasma with a hemoglobin concentration of only 6% and P50 value of 24\u2003mm\u2003Hg should be therapeutically effective even if less than 100\u2003mL of stabilized hemoglobin solution (conjugated hemoglobin of 90\u2003000\u2003Da with a molecular size of less than 10\u2003nm or 0.01\u2003\u00b5m) are infused under shock conditions. The basic physiology of oxygen\u2010carrying macromolecules is described in detail, which is different from the oxygen carried inside the red cells and inside encapsulated oxygen\u2010carrying particles (typically 250\u2003nm or 0.25\u2003\u00b5m). Thus, the oxygen\u2010carrying macromolecues are extremely effective in the treatment of shock patients. In emergency cases, after the bleeding is controlled, a small infusion volume of oxygen\u2010carrying macromolecules will supply sufficient oxygen to the hypoxic tissues and immediately improve the blood pressure of shock patients.\n                  <\/jats:p>","DOI":"10.1111\/j.1525-1594.2004.07393.x","type":"journal-article","created":{"date-parts":[[2004,8,20]],"date-time":"2004-08-20T03:31:16Z","timestamp":1092972676000},"page":"807-812","source":"Crossref","is-referenced-by-count":33,"title":["Is There a Role for Blood Substitutes in Civilian Medicine: A Drug for Emergency Shock Cases?"],"prefix":"10.1111","volume":"28","author":[{"given":"Yukihiko","family":"Nos\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,20]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1789","article-title":"Physiological effects of intravascular fluorocarbon liquids","volume":"29","author":"Nos\u00e9 Y","year":"1970","journal-title":"Fed Proc"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(70)90082-X"},{"key":"e_1_2_7_4_2","first-page":"358","article-title":"Flurocarbon as artificial red cells","volume":"72","author":"Ogawa H","year":"1970","journal-title":"Prog Med (Igaku-No-Ayumi)"},{"key":"e_1_2_7_5_2","first-page":"73","article-title":"Basic studies on biological effects of fluorocarbon as artificial red blood cells upon internal organs in rats","volume":"3","author":"Koiso K","year":"1974","journal-title":"Artif Organs (Jpn)"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1992.tb00321.x"},{"key":"e_1_2_7_7_2","volume-title":"Manual on Artificial Organs","author":"Nos\u00e9 Y","year":"1973"},{"key":"e_1_2_7_8_2","volume-title":"Proceedings of the International Symposium on Stabilized Hemoglobin.","author":"Hori M","year":"1987"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-198609000-00021"},{"key":"e_1_2_7_10_2","first-page":"17","volume-title":"The Proceedings of the International Symposium on Stabilized Hemoglobin.","author":"Matsushita M","year":"1987"},{"key":"e_1_2_7_11_2","first-page":"352","article-title":"Oxygen transport by a pyridoxalated\u2010hemoglobin\u2010polyoxyethylene conjugate","volume":"33","author":"Matsushita M","year":"1987","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_7_12_2","first-page":"280","article-title":"Renal effects of a pyridoxalated\u2010hemoglobin\u2010polyoxyethylene conjugate solution as a blood substitute in exchange transfusion","volume":"34","author":"Matsushita M","year":"1988","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_7_13_2","first-page":"773","article-title":"In vitro evaluation of a pyridoxalated\u2010hemoglobin\u2010polyoxyethylene conjugate in reversing cell sickling","volume":"34","author":"Yabuki A","year":"1988","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1557\/PROC-110-113"},{"key":"e_1_2_7_15_2","first-page":"365","article-title":"In vitro evaluation of stabilized hemoglobin for improvement of microcirculation in sickle cell anemia","volume":"18","author":"Yabuki A","year":"1989","journal-title":"Jpn J Artif Organs"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139889001300711"},{"key":"e_1_2_7_17_2","first-page":"215","article-title":"Effects of pyridoxalated\u2010hemoglobin\u2010polyoxyethylene conjugate on renal function and histology","volume":"14","author":"Takahashi T","year":"1990","journal-title":"Artif Organs"},{"key":"e_1_2_7_18_2","first-page":"130","volume-title":"Red Cell Substitutes. The Proceedings of the Second International Symposium of Red Cell Substitutes, Sapporo, 1989","author":"Malchesky PS","year":"1991"},{"key":"e_1_2_7_19_2","first-page":"462","article-title":"Effects of single\u2010dose infusion of pyridoxalated\u2010hemoglobin\u2010polyoxyethylene conjugate (PHP) solution on canine renal function","volume":"15","author":"Takahashi T","year":"1991","journal-title":"Artif Organs"},{"key":"e_1_2_7_20_2","first-page":"221","volume-title":"Biomaterials, Artificial Cells, and Immobilization Biotechnology, Special Issue of IV International Symposium on \u201cBlood Substitutes","author":"Minato N","year":"1992"}],"container-title":["Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1594.2004.07393.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1594.2004.07393.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T17:33:47Z","timestamp":1697218427000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1594.2004.07393.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,20]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1525-1594.2004.07393.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1594.2004.07393.x","archive":["Portico"],"relation":{},"ISSN":["0160-564X","1525-1594"],"issn-type":[{"value":"0160-564X","type":"print"},{"value":"1525-1594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,20]]}}}